The Effect of Blood Volume Changes on the Glucose Tolerance

NCT ID: NCT02612597

Last Updated: 2015-11-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2016-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study the investigators would like to elaborate on the mechanisms that lead to a higher insulin sensitivity after exercise training and a lower insulin sensitivity after bedrest.

The investigators speculate that the concomitant chances in blood volume during training and bedrest might explain the changed insulin sensitivity because with a changing blood volume also the dilution space of the glucose will change.

Furthermore, the investigators would like to work on the influence of a changed capacity of skeletal muscle for glucose uptake and glycogen storage on the glucose sensitivity.

Therefore, A) a bed rest study with healthy untrained subjects and B) a training study with obese pre-diabetic patients will be conducted.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

While there is little doubt that physical inactivity leads to reduced insulin sensitivity and in contrast hereto that physical activity improves insulin sensitivity the underlying mechanisms are still to a large extend unknown. With this study the investigators wish to test two independent hypotheses that may explain the observed changes:

The first hypothesis is that part of the explanation for the known increase in circulating levels of glucose in response to an oral glucose tolerance test (indicating reduced insulin sensitivity) following bed rest is due to a concomitantly reduced blood volume and thereby dilution space.

In addition the investigators also speculate that the reduced glucose response to an oral glucose tolerance test (indicating improved insulin sensitivity) after a training period is related to the exercise induced increase in blood volume, and hence an increased dilution space.

Based on this, the hypothesis to be tested with these two experimental approaches (bed rest and aerobic exercise training), is that at least part of the changes observed in the glucose tolerance following bed rest and aerobic exercise training are related to concomitantly occurring changes in blood volume.

The second hypothesis to be tested is that another important contributor to the changes in circulating glucose levels following an oral glucose tolerance test after bed rest and physical training are related to diminished or improved capacity for skeletal muscle glucose uptake and glycogen storage, respectively. The rationale here fore are that exercise training increases skeletal muscle glycogen content and storage capacity in healthy and type 2 diabetic patients, respectively, and that bed rest does the opposite.

To test this hypothesis two different intervention studies will be conducted. Study 1 is a bed rest study with healthy untrained subjects and study 2 is a training study with obese "pre-diabetic patients".

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Overweight

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bedrest

4 days of bedrest

Group Type EXPERIMENTAL

Bedrest

Intervention Type OTHER

Exercise Training

6 weeks of aerobic endurance exercise training with 4 supervised sessions per week at an average intensity of 65 % of maximal heart rate

Group Type EXPERIMENTAL

Exercise Training

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bedrest

Intervention Type OTHER

Exercise Training

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Informed consent as documented by signature
* Age: 18-35
* healthy (no chronic diseases)
* BMI: 19-25
* maximal oxygen uptake: 35-50 ml O2/min/kg


* Informed consent as documented by signature
* Age: 35-50
* BMI: 30-40
* Fat%: 30-40 %
* maximal oxygen uptake: 20-35 ml O2/min/kg
* HbA1c: 5.5 - 7.0 %

Exclusion Criteria

* chronic diseases
* any health problems that do not allow the subjects to participate in the measurements (i.e. heart defect)
* History of familiar history (1st grade relatives) of venous thrombic-embolism or renal insufficiency
* Blood donation in the last month
* Any medication with known influence on blood volume, glucose metabolism and body weight
* Stay above 2500 m for more than 1 day
* Known allergies against Fragmin or Heparin

Training:


* Chronic diseases
* Any health problems that do not allow the subjects to participate in the measurements (i.e. heart defect)
* Blood donation in the last month
* Any medication with known influence on blood volume, glucose metabolism and body weight
* Stay above 2500 m for more than 1 day
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Carsten Lundby

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Carsten Lundby

Prof. Dr.

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carsten Lundby, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

Institute of Physiology, University of Zurich

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute of Physiology, University of Zurich

Zurich, Canton of Zurich, Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Carsten Lundby, Prof. Dr.

Role: CONTACT

+41 44 635 50 52 ext. +41

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Carsten Lundby, Prof. Dr.

Role: primary

+41 44 635 50 52 ext. +41

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KEK-ZH-Nr. 2015-0453

Identifier Type: -

Identifier Source: org_study_id